Skip to main content
. Author manuscript; available in PMC: 2015 May 21.
Published in final edited form as: Mol Immunol. 2012 Feb 24;50(4):244–252. doi: 10.1016/j.molimm.2012.01.011

Fig. 3.

Fig. 3

IRAK-1 is required for LPS-mediated suppression of GPx. The activities of GPx following either LPS or PBS injection were measured in liver (A), kidney (B) and brain (C) tissues of WT and IRAK-1 deficient mice. Data is expressed as mean ± SD (N = 4) of at least three independent experiments. *P < 0.05.